In addition, eight hub genes of CCNE1, CENPN, CHEK1, PLK1, DSCC1, FAM64A, UBE2C, and UBE2T were identified and validated to be the potential prognostic and therapeutic biomarkers for breast cancer subtypes. This evidence concerns the gene DSCC1 and breast carcinoma.